EUVIMEDEUVIMED entdecken
Open Access · CC0

Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) expressions in Ethiopian female breast cancer and their association with histopathologic features

Sisay Addisu iD, Abebe Bekele iD, Daniel Seifu, Mathewos Assefa, Tufa Gemechu, Mark J Hoenerhoff, Sofia D Merajver

PLOS ONE · 15.10.2024 · 19 (10) · e0308411

DOI: 10.1371/journal.pone.0308411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 15.10.2024. Verfasst von Sisay Addisu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: ErbB Receptors, Vascular Endothelial Growth Factor A, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Addis Ababa University and International Reproductive Health Training.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGF) play important role in breast tumor growth, invasion, metastasis, patient survival and drug resistance. The aim of this study was to evaluate the protein expression status of EGFR and VEGF-A, as well as their association with hormone receptor status and histopathological characteristics in the invasive type of female breast cancer among Ethiopians.

Method

The primary breast tumor tissues were obtained from 85 Ethiopian invasive breast cancer cases that underwent modified radical mastectomy (MRM) from June 2014 to June 2015. Their FFPE blocks were analyzed for EGFR and VEGF protein expressions using immunohistochemical techniques. The expressions were also correlated with histopathologic features.

Result

Epidermal growth factor receptor over-expression was observed in 22% of the tumor samples. VEGF-A expression was negative in 13.41%, low in 63.41%, moderate in 20.73%, and high in 2.44%. EGFR expression, but not VEGF-A, showed a significant inverse correlation with both estrogen receptor (ER) ( P = 0.01) and progesterone receptor (PR) statuses ( P = 0.04). EGFR and VEGF expressions did not show significant association with tumor size, grade, lymph node status or age at diagnosis.

Conclusion

Epidermal growth factor receptor expression was most likely associated with ER and PR negative tumors. Assessments of multiple molecular markers aid to understand the biological behavior of the disease in Ethiopian population. It might also help to predict which group of patients might get more benefit from the selected treatment strategies and which are not.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsVascular Endothelial Growth Factor ABreast NeoplasmsHumansFemaleMiddle AgedAdultEthiopiaAgedReceptors, ProgesteroneReceptors, EstrogenImmunohistochemistry

Substanzen

ErbB ReceptorsVascular Endothelial Growth Factor AEGFR protein, humanVEGFA protein, humanReceptors, ProgesteroneReceptors, Estrogen

Autor:innen und Institutionen

  • Department of Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • Department of Surgery, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • Department of Internal Medicine, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • Department of Pathology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • In Vivo Animal Core, Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
  • Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States of America.

ORCID-Profile: Sisay Addisu, Abebe Bekele

Förderung

  • Addis Ababa University and International Reproductive Health Training

Zitieren

APA

Addisu, S., Bekele, A., Seifu, D., Assefa, M., Gemechu, T., Hoenerhoff, M. J., & Merajver, S. D. (2024). Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) expressions in Ethiopian female breast cancer and their association with histopathologic features. PLOS ONE, 19(10), e0308411. https://doi.org/10.1371/journal.pone.0308411

Vancouver

Addisu S, Bekele A, Seifu D, Assefa M, Gemechu T, Hoenerhoff MJ, et al. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) expressions in Ethiopian female breast cancer and their association with histopathologic features. PLOS ONE. 2024;19(10):e0308411. doi:10.1371/journal.pone.0308411

BibTeX
@article{Addisu2024,
  author = {Addisu, Sisay and Bekele, Abebe and Seifu, Daniel and Assefa, Mathewos and Gemechu, Tufa and Hoenerhoff, Mark J and Merajver, Sofia D},
  title = {Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) expressions in Ethiopian female breast cancer and their association with histopathologic features},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {10},
  pages = {e0308411},
  doi = {10.1371/journal.pone.0308411}
}
Kostenlos starten →